-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROSENSE THERAPEUTICS LTD: DOSSIER SUBMISSION PLANNED FOR Q2 2025; REGULATORY DECISION EXPECTED BY Q1 2026

Reuters·10/15/2024 13:15:09

Please log in to view news